Correlation Between Tscan Therapeutics and Hudson Pacific

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Hudson Pacific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Hudson Pacific into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and Hudson Pacific Properties, you can compare the effects of market volatilities on Tscan Therapeutics and Hudson Pacific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Hudson Pacific. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Hudson Pacific.

Diversification Opportunities for Tscan Therapeutics and Hudson Pacific

-0.13

Correlation Coefficient

Tscan Therapeutics  Hudson Pacific

Good diversification

The 3 months correlation between Tscan and Hudson is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Hudson Pacific Properties in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hudson Pacific Properties and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Hudson Pacific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hudson Pacific Properties has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Hudson Pacific go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Hudson Pacific

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Hudson Pacific. In addition to that, Tscan Therapeutics is 1.01 times more volatile than Hudson Pacific Properties. It trades about -0.25 of its total potential returns per unit of risk. Hudson Pacific Properties is currently generating about 0.04 per unit of volatility. If you would invest  289.00  in Hudson Pacific Properties on December 28, 2024 and sell it today you would earn a total of  12.00  from holding Hudson Pacific Properties or generate 4.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tscan Therapeutics  vs.  Hudson Pacific Properties

Tscan Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Hudson Pacific Properties

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Hudson Pacific Properties are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Hudson Pacific may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Tscan Therapeutics and Hudson Pacific

The main advantage of trading using opposite Tscan Therapeutics and Hudson Pacific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Hudson Pacific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hudson Pacific will offset losses from the drop in Hudson Pacific's long position.

The idea behind Tscan Therapeutics and Hudson Pacific Properties pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.